Evidence map›Paper›PMID 31546658›Full record

ArticleGenes2019

Aberrant Splicing Events Associated to

Rebeca Valero, Marta de Castro-Miró, Sofía Jiménez-Ochoa, Juan José Rodríguez-Ezcurra, Gemma Marfany, Roser Gonzàlez-Duarte

Open access · goldAbstract read
In one paragraph

Article in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in genetics · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Missense Variant of Endoplasmic Reticulum Region ofBioMed research international · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Rebeca ValeroDBGen Ocular Genomics, 08028 Barcelona, Spain. rvalero@ub.edu.
Marta de Castro-MiróDBGen Ocular Genomics, 08028 Barcelona, Spain. martadecastromiro@ub.edu.
Sofía Jiménez-OchoaDBGen Ocular Genomics, 08028 Barcelona, Spain. sofiacorella96@gmail.com.
Juan José Rodríguez-EzcurraBarraquer-Centro de Oftalmología Barcelona, 08021 Barcelona, Spain. jrezcurra@barraquer.com.
Gemma MarfanyDBGen Ocular Genomics, 08028 Barcelona, Spain. gmarfany@ub.edu.ORCID 0000-0001-7941-983X
Roser Gonzàlez-DuarteDBGen Ocular Genomics, 08028 Barcelona, Spain. rgonzalez@dbgen.com.
Oryzon Genomics (Spain) · ESBarraquer Opthalmology Center · ESCentre for Biomedical Network Research on Rare Diseases · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe aim of this study was the genetic diagnosis by next generation sequencing (NGS) of a patient diagnosed with Usher syndrome type 2 and the functional evaluation of the identified genetic variants to establish a phenotype-genotype correlation.

methodsWhole exome sequencing (WES) analysis identified two heterozygous intronic variants in

resultsTwo intronic variants were identified in intron 45 of

conclusionsA combination of in vivo and in vitro assays provided a comprehensive view of the physiological effects of NCSS variants, which in this case led to a clinical reassignment of the proband as affected with atypical USH1 syndrome.

Indexed as

AdultAlternative SplicingCadherin Related ProteinsCadherinsDNA Mutational AnalysisExome SequencingExonsFemaleHEK293 CellsHumansMutationUsher SyndromesCadherin Related ProteinsCadherinsCDH23 protein, humanCDH23functional analysisphenotypic effectssplice site variantsUsher syndrome

Identifiers

PMID31546658
PMCPMC6826400
OpenAlexW2974662867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.